State Street

State Street’s ADC Therapeutics ADCT Stock Holding History

State Street’s Portfolio ADCT Stock Details ADCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.87M	Buy	1,566,662 +159,337	+11%	+$628K	﹤0.01%	2885
2025 Q4	$4.97M	Buy	1,407,325 +111,384	+9%	+$452K	﹤0.01%	2994
2025 Q3	$5.18M	Buy	1,295,941 +61,468	+5%	+$194K	﹤0.01%	2979
2025 Q2	$3.31M	Buy	1,234,473 +23,127	+2%	+$48.6K	﹤0.01%	3115
2025 Q1	$1.71M	Buy	1,211,346 +23,152	+2%	+$39.3K	﹤0.01%	3302
2024 Q4	$2.36M	Buy	1,188,194 +82,183	+7%	+$215K	﹤0.01%	3262
2024 Q3	$3.48M	Buy	1,106,011 +114,715	+12%	+$362K	﹤0.01%	3115
2024 Q2	$3.13M	Buy	+991,296	New	+$3.94M	﹤0.01%	3128
2022 Q3	–	Sell	-14,028	Closed	-$112K	–	4932
2022 Q2	$112K	Buy	+14,028	New	+$133K	﹤0.01%	4474

Other funds holding ADCT

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return